Study in Predicting Outcome of Patients Undergoing Radiation Therapy for Prostate Cancer

Completed · Not applicable

Conditions studied: Prostate Cancer

In brief

RATIONALE: Proteins found in blood and urine samples may help predict outcome and allow doctors to plan more effective treatment. PURPOSE: Diagnostic trial to study blood and urine proteins in predicting treatment outcome in patients who are undergoing radiation therapy for prostate cancer.

Key facts

Study ID

NCT00045331

Run by

National Cancer Institute (NCI)

Starts

2002-08-01

Expected to finish

2007-10-01

Last updated by the study team

2013-06-19

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

Where it is running

• Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support — Bethesda, Maryland, United States
• NCI - Center for Cancer Research — Bethesda, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.